PDB Short entry for 5A5J HEADER OXIDOREDUCTASE 18-JUN-15 5A5J TITLE CYTOCHROME 2C9 P450 INHIBITOR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 2C9; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 23-489; COMPND 5 SYNONYM: (R)-LIMONENE 6-MONOOXYGENASE, (S)-LIMONENE COMPND 6 6-MONOOXYGENASE, (S)-LIMONENE 7-MONOOXYGENASE, CYPIIC9, CYTOCHROME COMPND 7 P-450MP, CYTOCHROME P450 MP-4, CYTOCHROME P450 MP-8, CYTOCHROME COMPND 8 P450 PB-1, S-MEPHENYTOIN 4-HYDROXYLASE, CYTOCHROME 2C9; COMPND 9 EC: 1.14.99.38; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR S.E.SKERRATT,M.J.DE GROOT,C.PHILLIPS REVDAT 1 03-AUG-16 5A5J 0 JRNL AUTH S.E.SKERRATT,M.J.DE GROOT,C.PHILLIPS JRNL TITL DISCOVERY OF A NOVEL BINDING POCKET FOR CYP 2C9 INHIBITORS: JRNL TITL 2 CRYSTALLOGRAPHY, PHARMACOPHORE MODELLING AND INHIBITOR SAR. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU, REMARK 3 STEINER,NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 71.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 99.70 REMARK 3 NUMBER OF REFLECTIONS : 11096 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.21655 REMARK 3 R VALUE (WORKING SET) : 0.21303 REMARK 3 FREE R VALUE : 0.28792 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.8 REMARK 3 FREE R VALUE TEST SET COUNT : 555 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.900 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.975 REMARK 3 REFLECTION IN BIN (WORKING SET) : 827 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.416 REMARK 3 BIN FREE R VALUE SET COUNT : 44 REMARK 3 BIN FREE R VALUE : 0.494 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3646 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.203 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.18 REMARK 3 B22 (A**2) : -0.18 REMARK 3 B33 (A**2) : 0.60 REMARK 3 B12 (A**2) : -0.09 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.490 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.430 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 23.539 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3785 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3656 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5129 ; 1.496 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8444 ; 0.986 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 452 ; 7.204 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 166 ;38.286 ;24.036 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 672 ;19.692 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;20.353 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 561 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4193 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 863 ; 0.004 ; 0.020 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1817 ; 3.565 ; 5.784 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1816 ; 3.545 ; 5.781 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2266 ; 6.010 ; 8.656 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2267 ; 6.013 ; 8.661 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1968 ; 2.865 ; 6.063 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1966 ; 2.866 ; 6.066 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2863 ; 4.849 ; 8.963 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4241 ; 8.279 ;44.992 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4242 ; 8.278 ;44.990 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 5A5J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-JUN-15. REMARK 100 THE PDBE ID CODE IS EBI-64106. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11653 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.90 REMARK 200 RESOLUTION RANGE LOW (A) : 29.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.12 REMARK 200 R MERGE (I) : 0.10 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.70 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 45.64500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.35315 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 56.45667 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 45.64500 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 26.35315 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 56.45667 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 45.64500 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 26.35315 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.45667 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 52.70631 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 112.91333 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 52.70631 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 112.91333 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 52.70631 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 112.91333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 18 REMARK 465 ALA A 19 REMARK 465 LYS A 20 REMARK 465 LYS A 21 REMARK 465 THR A 22 REMARK 465 SER A 23 REMARK 465 SER A 24 REMARK 465 GLY A 25 REMARK 465 VAL A 38 REMARK 465 ILE A 39 REMARK 465 GLY A 40 REMARK 465 ASN A 41 REMARK 465 ILE A 42 REMARK 465 GLN A 214 REMARK 465 ILE A 215 REMARK 465 CYS A 216 REMARK 465 ASN A 217 REMARK 465 ASN A 218 REMARK 465 PHE A 219 REMARK 465 SER A 220 REMARK 465 HIS A 493 REMARK 465 HIS A 494 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 72 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 172 CB - CA - C ANGL. DEV. = -8.4 DEGREES REMARK 500 ASP A 256 CB - CG - OD1 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP A 265 CB - CG - OD2 ANGL. DEV. = 7.0 DEGREES REMARK 500 ASP A 341 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 349 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 CYS A 372 CA - CB - SG ANGL. DEV. = -11.7 DEGREES REMARK 500 ASP A 373 CB - CG - OD1 ANGL. DEV. = 8.3 DEGREES REMARK 500 ASP A 397 CB - CG - OD2 ANGL. DEV. = 7.1 DEGREES REMARK 500 ASP A 408 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP A 463 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 35 177.04 -37.78 REMARK 500 LEU A 36 -19.10 92.91 REMARK 500 ILE A 88 -61.02 -96.98 REMARK 500 PHE A 100 -179.33 85.77 REMARK 500 PRO A 101 -20.76 -36.00 REMARK 500 LEU A 102 -173.42 -175.13 REMARK 500 GLU A 104 109.48 100.08 REMARK 500 ALA A 106 3.86 -66.15 REMARK 500 ASN A 107 87.71 39.32 REMARK 500 LEU A 128 -58.68 -28.58 REMARK 500 ASN A 133 54.30 83.17 REMARK 500 MET A 136 40.00 -140.42 REMARK 500 ALA A 161 -8.51 85.01 REMARK 500 HIS A 184 -5.78 86.85 REMARK 500 ARG A 186 -176.61 -58.42 REMARK 500 ASP A 188 156.46 -47.63 REMARK 500 LEU A 195 -16.52 -49.54 REMARK 500 PHE A 226 -48.20 160.82 REMARK 500 THR A 229 -31.57 -144.10 REMARK 500 ASP A 256 86.53 -179.37 REMARK 500 MET A 257 -47.54 -21.91 REMARK 500 ASN A 259 69.84 -156.91 REMARK 500 GLU A 274 60.64 -114.71 REMARK 500 HIS A 276 3.68 55.38 REMARK 500 GLU A 325 -70.07 -54.11 REMARK 500 GLU A 326 -29.85 -36.17 REMARK 500 ASN A 334 -76.18 -76.85 REMARK 500 SER A 365 -146.60 51.25 REMARK 500 HIS A 368 -167.87 -103.21 REMARK 500 ALA A 369 135.92 -174.23 REMARK 500 ARG A 377 -113.94 48.13 REMARK 500 ASN A 378 52.69 -109.67 REMARK 500 LYS A 383 138.41 -31.54 REMARK 500 LYS A 423 -34.98 -37.63 REMARK 500 SER A 429 -156.19 97.78 REMARK 500 PRO A 464 -47.71 -21.78 REMARK 500 LEU A 467 106.06 -22.58 REMARK 500 HIS A 491 120.69 -171.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 489 ILE A 490 -141.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 PHE A 476 21.1 L L OUTSIDE RANGE REMARK 500 HIS A 491 24.9 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A1493 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 435 SG REMARK 620 2 HEM A1493 NA 96.4 REMARK 620 3 HEM A1493 NB 89.7 83.7 REMARK 620 4 HEM A1493 NC 89.3 170.8 89.2 REMARK 620 5 HEM A1493 ND 96.3 88.2 170.4 98.3 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A1493 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 6YF A1494 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5A5I RELATED DB: PDB REMARK 900 CYTOCHROME 2C9 P450 INHIBITOR COMPLEX DBREF 5A5J A 23 489 UNP P11712 CP2C9_HUMAN 23 489 SEQADV 5A5J MET A 18 UNP P11712 EXPRESSION TAG SEQADV 5A5J ALA A 19 UNP P11712 EXPRESSION TAG SEQADV 5A5J LYS A 20 UNP P11712 EXPRESSION TAG SEQADV 5A5J LYS A 21 UNP P11712 EXPRESSION TAG SEQADV 5A5J THR A 22 UNP P11712 EXPRESSION TAG SEQADV 5A5J ILE A 490 UNP P11712 EXPRESSION TAG SEQADV 5A5J HIS A 491 UNP P11712 EXPRESSION TAG SEQADV 5A5J HIS A 492 UNP P11712 EXPRESSION TAG SEQADV 5A5J HIS A 493 UNP P11712 EXPRESSION TAG SEQADV 5A5J HIS A 494 UNP P11712 EXPRESSION TAG SEQRES 1 A 477 MET ALA LYS LYS THR SER SER GLY ARG GLY LYS LEU PRO SEQRES 2 A 477 PRO GLY PRO THR PRO LEU PRO VAL ILE GLY ASN ILE LEU SEQRES 3 A 477 GLN ILE GLY ILE LYS ASP ILE SER LYS SER LEU THR ASN SEQRES 4 A 477 LEU SER LYS VAL TYR GLY PRO VAL PHE THR LEU TYR PHE SEQRES 5 A 477 GLY LEU LYS PRO ILE VAL VAL LEU HIS GLY TYR GLU ALA SEQRES 6 A 477 VAL LYS GLU ALA LEU ILE ASP LEU GLY GLU GLU PHE SER SEQRES 7 A 477 GLY ARG GLY ILE PHE PRO LEU ALA GLU ARG ALA ASN ARG SEQRES 8 A 477 GLY PHE GLY ILE VAL PHE SER ASN GLY LYS LYS TRP LYS SEQRES 9 A 477 GLU ILE ARG ARG PHE SER LEU MET THR LEU ARG ASN PHE SEQRES 10 A 477 GLY MET GLY LYS ARG SER ILE GLU ASP ARG VAL GLN GLU SEQRES 11 A 477 GLU ALA ARG CYS LEU VAL GLU GLU LEU ARG LYS THR LYS SEQRES 12 A 477 ALA SER PRO CYS ASP PRO THR PHE ILE LEU GLY CYS ALA SEQRES 13 A 477 PRO CYS ASN VAL ILE CYS SER ILE ILE PHE HIS LYS ARG SEQRES 14 A 477 PHE ASP TYR LYS ASP GLN GLN PHE LEU ASN LEU MET GLU SEQRES 15 A 477 LYS LEU ASN GLU ASN ILE LYS ILE LEU SER SER PRO TRP SEQRES 16 A 477 ILE GLN ILE CYS ASN ASN PHE SER PRO ILE ILE ASP TYR SEQRES 17 A 477 PHE PRO GLY THR HIS ASN LYS LEU LEU LYS ASN VAL ALA SEQRES 18 A 477 PHE MET LYS SER TYR ILE LEU GLU LYS VAL LYS GLU HIS SEQRES 19 A 477 GLN GLU SER MET ASP MET ASN ASN PRO GLN ASP PHE ILE SEQRES 20 A 477 ASP CYS PHE LEU MET LYS MET GLU LYS GLU LYS HIS ASN SEQRES 21 A 477 GLN PRO SER GLU PHE THR ILE GLU SER LEU GLU ASN THR SEQRES 22 A 477 ALA VAL ASP LEU PHE GLY ALA GLY THR GLU THR THR SER SEQRES 23 A 477 THR THR LEU ARG TYR ALA LEU LEU LEU LEU LEU LYS HIS SEQRES 24 A 477 PRO GLU VAL THR ALA LYS VAL GLN GLU GLU ILE GLU ARG SEQRES 25 A 477 VAL ILE GLY ARG ASN ARG SER PRO CYS MET GLN ASP ARG SEQRES 26 A 477 SER HIS MET PRO TYR THR ASP ALA VAL VAL HIS GLU VAL SEQRES 27 A 477 GLN ARG TYR ILE ASP LEU LEU PRO THR SER LEU PRO HIS SEQRES 28 A 477 ALA VAL THR CYS ASP ILE LYS PHE ARG ASN TYR LEU ILE SEQRES 29 A 477 PRO LYS GLY THR THR ILE LEU ILE SER LEU THR SER VAL SEQRES 30 A 477 LEU HIS ASP ASN LYS GLU PHE PRO ASN PRO GLU MET PHE SEQRES 31 A 477 ASP PRO HIS HIS PHE LEU ASP GLU GLY GLY ASN PHE LYS SEQRES 32 A 477 LYS SER LYS TYR PHE MET PRO PHE SER ALA GLY LYS ARG SEQRES 33 A 477 ILE CYS VAL GLY GLU ALA LEU ALA GLY MET GLU LEU PHE SEQRES 34 A 477 LEU PHE LEU THR SER ILE LEU GLN ASN PHE ASN LEU LYS SEQRES 35 A 477 SER LEU VAL ASP PRO LYS ASN LEU ASP THR THR PRO VAL SEQRES 36 A 477 VAL ASN GLY PHE ALA SER VAL PRO PRO PHE TYR GLN LEU SEQRES 37 A 477 CYS PHE ILE PRO ILE HIS HIS HIS HIS HET HEM A1493 43 HET 6YF A1494 28 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM 6YF N-[4-(3-CHLORANYL-4-CYANO-PHENOXY)-3,5- HETNAM 2 6YF DIMETHOXY-PHENYL]-1,1,1-TRIS(FLUORANYL) HETNAM 3 6YF METHANESULFONAMIDE HETSYN HEM HEME FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 6YF C16 H12 CL F3 N2 O5 S HELIX 1 1 GLY A 46 GLY A 62 1 17 HELIX 2 2 GLY A 79 ILE A 88 1 10 HELIX 3 3 GLY A 91 PHE A 94 5 4 HELIX 4 4 ASN A 116 LEU A 131 1 16 HELIX 5 5 SER A 140 LYS A 158 1 19 HELIX 6 6 PRO A 166 PHE A 183 1 18 HELIX 7 7 ASP A 191 SER A 209 1 19 HELIX 8 8 THR A 229 SER A 254 1 26 HELIX 9 9 ASP A 262 GLU A 274 1 13 HELIX 10 10 THR A 283 GLY A 332 1 50 HELIX 11 11 CYS A 338 SER A 343 1 6 HELIX 12 12 MET A 345 ASP A 360 1 16 HELIX 13 13 SER A 390 HIS A 396 1 7 HELIX 14 14 ASP A 408 PHE A 412 5 5 HELIX 15 15 ALA A 430 ILE A 434 5 5 HELIX 16 16 GLY A 437 ASN A 455 1 19 SHEET 1 AA 5 VAL A 64 LEU A 67 0 SHEET 2 AA 5 ILE A 74 LEU A 77 -1 O ILE A 74 N LEU A 67 SHEET 3 AA 5 THR A 386 ILE A 389 1 O THR A 386 N VAL A 75 SHEET 4 AA 5 HIS A 368 ALA A 369 -1 O HIS A 368 N ILE A 387 SHEET 5 AA 5 GLY A 96 ARG A 97 -1 O GLY A 96 N ALA A 369 SHEET 1 AB 2 ILE A 374 LYS A 375 0 SHEET 2 AB 2 LEU A 380 ILE A 381 -1 O ILE A 381 N ILE A 374 SHEET 1 AC 2 PHE A 456 SER A 460 0 SHEET 2 AC 2 LEU A 485 PRO A 489 -1 O CYS A 486 N LYS A 459 LINK SG CYS A 435 FE HEM A1493 1555 1555 2.28 CISPEP 1 GLN A 278 PRO A 279 0 -17.03 SITE 1 AC1 19 ARG A 97 ILE A 112 TRP A 120 ALA A 297 SITE 2 AC1 19 GLY A 298 THR A 301 THR A 302 LEU A 361 SITE 3 AC1 19 SER A 365 HIS A 368 PRO A 427 PHE A 428 SITE 4 AC1 19 SER A 429 ARG A 433 CYS A 435 VAL A 436 SITE 5 AC1 19 GLY A 437 LEU A 440 ALA A 441 SITE 1 AC2 13 ARG A 108 PHE A 114 LEU A 201 ILE A 205 SITE 2 AC2 13 LEU A 208 SER A 209 GLY A 296 ALA A 297 SITE 3 AC2 13 GLU A 300 THR A 304 ASN A 474 PHE A 476 SITE 4 AC2 13 VAL A 479 CRYST1 91.290 91.290 169.370 90.00 90.00 120.00 H 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010954 0.006324 0.000000 0.00000 SCALE2 0.000000 0.012649 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005904 0.00000